59. Forbearance practices
Forbearance is defined by the Group as actions aimed at amending contractual terms agreed with a debtor or an issuer, forced by the debtor’s or issuer’s difficult financial situation (restructuring activities introducing concessions that otherwise would not have been granted). The aim of forbearance activities is to restore a debtor’s or an issuer’s ability to settle their liabilities towards the Group and to maximize the efficiency of non-performing loans management, i.e. obtaining the highest possible recoveries while minimizing the costs incurred.
Forbearance changes in repayment terms may consist of:
- dividing the debt due into instalments;
- changing the repayment scheme (annuity payments, degressive payments);
- extending the loan period;
- changing the interest rate;
- changing the margin;
- reducing the debt.
As a result of concluding a forbearance agreement and repaying the amounts due under it on a timely basis, a non-performing loan becomes a performing loan.
The provision of facilities within the framework of forbearance, as a premise of impairment, results in the recognition of the premise of impairment and the classification of the credit exposure into the portfolio of exposures at risk of impairment.
The inclusion of such exposures in the portfolio of performing exposures (discontinuing recognition of the forbearance agreement as an impairment trigger) takes place at least 12 months after the introduction of forbearance, provided that all payments in arrears and at least six scheduled payments have been made by the customer and, in the Group’s opinion, the current situation of the customer does not pose a threat to their compliance with the terms of the restructuring agreement (except where the forbearance agreement comprises reducing the receivables) (principal, interest or fees) by more than 1%).
Exposures cease to meet the criteria of a forborne exposure when all of the following conditions are met:
- at least 24 months have passed from the date of including the exposure into the portfolio of performing exposures (conditional period);
- as at the end of the conditional period referred to above, the customer has no debt towards the Group overdue for more than 30 days;
- at least 12 instalments have been repaid on a timely basis and in the amounts agreed.
Forborne exposures are monitored on an on-going basis. Throughout the whole period of their recognition allowances are recognized for these exposures in the amount of expected losses over the life horizon of the exposure.
Non-performing exposures are understood as on-balance sheet exposures to an obligor that are past due by more than 90 days and the gross carrying amount of the past due exposures represents more than 20% of the gross carrying amount of all on-balance sheet exposures to that obligor.
31.12.2023 | Instruments with modified terms and conditions | Refinancing | Total gross | Impairment losses | Total, net |
---|---|---|---|---|---|
Performing exposures | |||||
Not held for trading, measured at fair value through profit or loss | 11 | – | 11 | – | 11 |
consumer loans | 11 | – | 11 | – | 11 |
Measured at amortized cost: | 633 | 1 | 634 | (51) | 583 |
housing loans | 152 | – | 152 | (12) | 140 |
business loans | 358 | 1 | 359 | (25) | 334 |
consumer loans | 114 | – | 114 | (14) | 100 |
finance lease receivables | 9 | – | 9 | – | 9 |
Total performing exposures | 644 | 1 | 645 | (51) | 594 |
Non-performing exposures | |||||
Not held for trading, measured at fair value through profit or loss | 71 | – | 71 | – | 71 |
consumer loans | 25 | – | 25 | – | 25 |
corporate bonds | 46 | – | 46 | – | 46 |
Measured at fair value through OCI: | 12 | – | 12 | – | 12 |
corporate bonds | 12 | – | 12 | – | 12 |
Measured at amortized cost: | 1,593 | 32 | 1,625 | (707) | 918 |
housing loans | 287 | – | 287 | (194) | 93 |
business loans | 1,100 | 29 | 1,129 | (478) | 651 |
consumer loans | 158 | 3 | 161 | (7) | 154 |
finance lease receivables | 48 | – | 48 | (28) | 20 |
Total non-performing exposures | 1,676 | 32 | 1,708 | (707) | 1,001 |
TOTAL EXPOSURES SUBJECT TO FORBEARANCE | 2,320 | 33 | 2,353 | (758) | 1,595 |
31.12.2022 | Instruments with modified terms and conditions | Refinancing | Total gross | Impairment losses | Total, net |
---|---|---|---|---|---|
Performing exposures | |||||
Not held for trading, measured at fair value through profit or loss | 12 | – | 12 | – | 12 |
consumer loans | 12 | – | 12 | – | 12 |
Measured at amortized cost: | 755 | 2 | 757 | (57) | 700 |
housing loans | 213 | – | 213 | (12) | 201 |
business loans | 350 | 2 | 352 | (24) | 328 |
consumer loans | 103 | – | 103 | (13) | 90 |
finance lease receivables | 89 | – | 89 | (8) | 81 |
Total performing exposures | 767 | 2 | 769 | (57) | 712 |
Non-performing exposures | |||||
Not held for trading, measured at fair value through profit or loss | 74 | – | 74 | – | 74 |
consumer loans | 29 | – | 29 | – | 29 |
corporate bonds | 45 | – | 45 | – | 45 |
Measured at fair value through OCI: | 374 | – | 374 | 2 | 376 |
corporate bonds | 374 | – | 374 | 2 | 376 |
Measured at amortized cost: | 1,754 | 45 | 1,799 | (856) | 943 |
housing loans | 356 | – | 356 | (251) | 105 |
business loans | 1,200 | 42 | 1,242 | (554) | 688 |
consumer loans | 176 | 3 | 179 | (40) | 139 |
factoring receivables | 7 | – | 7 | (2) | 5 |
finance lease receivables | 15 | – | 15 | (9) | 6 |
Total non-performing exposures | 2,202 | 45 | 2,247 | (854) | 1,393 |
TOTAL EXPOSURES SUBJECT TO FORBEARANCE | 2,969 | 47 | 3,016 | (911) | 2,105 |
LOANS AND ADVANCES TO CUSTOMERS SUBJECT TO FORBEARANCE | 2023 | 2022 |
---|---|---|
Recognized interest income on forborne loans and advances granted to customers | 200 | 143 |